Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Relapsing MS Resource Center

Discover an appropriate RMS treatment for newly diagnosed patients or for patients who want or may want a change.

Can Losing Weight Reduce Alzheimer's Risk?

Among elderly adults with Alzheimer's disease, those who were overweight at age 50 tended to develop dementia earlier

Malaria Drugs: Future for Parkinson's Disease? ...

Anti-malarial drugs may be a potential treatment option for Parkinson's disease.

Driving Straight' and Dementia

Drivers with dementia who have more difficulties driving straight and making left and right turns are more likely to fail road testing.

Trans Fats Bad for the Memory

A new study reports that greater consumption of dietary trans fatty acids (dTFA) is strongly linked to worsening memory in men aged 45 and older, compared to men who consume no dTFA.

Omega-3s and Alzheimer's Risk

Consuming more omega-3 fatty acids may benefit some patients at risk for Alzheimer's disease.

Placebo Effect in Marijuana-Dementia Study?

Low-dose oral tetrahydrocannabinol (THC) may not ease the common behavioral symptoms that affect people with dementia

Seizure Drug Boosts MS Patient Eyesight

New research suggests that a medication indicated to treat seizures could also reduce the risk of nerve damage and blindness in patients with multiple sclerosis (MS).

Air Pollution's Effects on the Brain

Long-term exposure to ambient air pollution may be linked to subtle changes in the brain that could lead to cognitive impairment, a new study suggests.


High Rate of Concussion Linked to Isolated Mandible Fractures

Mechanism of injury assault in 12 of 16 patients; half of patients admit alcohol use

New Drug for Tardive Dyskinesia Demonstrates Efficacy in Phase 3 Study

Neurocrine Biosciences announced positive results from its Kinect 3 study, showing that NBI-98854 achieved a statistically significant reduction in tardive dyskinesia during the 6 weeks of treatment in patients with underlying schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder.

Lower Relapse Rates With Daclizumab for MS vs. Standard Therapy

Multiple sclerosis patients taking daclizumab high yield process (HYP), a humanized monoclonal antibody that binds to CD25 (alpha subunit of the interleukin-2 receptor) and modulates interleukin-2 signaling, experienced lower relapse rates but more side effects than patients receiving interferon beta-1a, new research indicates.

No Improved Outcomes Seen With Therapeutic Hypothermia in TBI

For patients with traumatic brain injury, therapeutic hypothermia plus standard care does not improve outcome over standard care alone, according to a study published in the New England Journal of Medicine.


Neurological Complications Caused by "Skinny Jeans"

Neurological Complications Caused by "Skinny Jeans"

So-called "skinny jeans" (slim-fitting jeans tapered at the ankle) are a fashion statement to many but could also be a health risk when combined with excess squatting, according to a case report published online in the Journal of Neurology, Neurosurgery & Psychiatry.

Prescription Drug Interaction with Ginseng Leads to DRESS Syndrome

Prescription Drug Interaction with Ginseng Leads to DRESS Syndrome

A case study in Pharmacotherapy describes the first known instance of a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome likely induced by a drug interaction between lamotrigine and ginseng.

Seizures Return After Initiating Vilazodone for MDD

Seizures Return After Initiating Vilazodone for MDD

Seizures induced by selective serotonin reuptake inhibitor (SSRI) use are rare and are more likely to be linked to larger doses and severe symptoms (such as those present in serotonin syndrome), but a new case study in the journal Pharmacotherapy described a patient that developed seizures after vilazodone treatment was initiated.

Featured courses from mycme

Comprehensive Review of NeurologyExternal web site

Keep on top of this rapidly evolving specialty area and improve assessment and care of ...

CME 41.50 Credits

Poor Glycemic Control Boosts Dementia RiskExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Cognitive Decline With Low Vitamin D: Not Just for WhitesExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters